来自Castanopsis calathiformis的未经描述的三类藻素及其潜在的抗增殖和低血糖活性
Ya-Feng Wang1, Ying-Rong Bao1, Rui-Jie He1
1Guangxi Key Laboratory of Plant Functional Phytochemicals and Sustainable Utilization, Guangxi Institute of Botany, Guangxi Zhuang Autonomous Region and Chinese Academy of Sciences, Guilin, 541006, China.
Phytochemistry
|March 11, 2026
概括
来自Castanopsis calathiformis的新型三烯酸拉基坦宁显示出强大的α-葡萄糖酶抑制活性. 六种新型化合物被分离出来,其中几种在抑制这种酶方面表现出显著的潜力,为糖尿病研究提供了新的途径.
科学领域:
- 自然产品 化学 化学
- 药用化学 医学化学
- 药理学是指药理学,即药理学是指药理学.
背景情况:
- 三聚烯酸拉基坦宁是植物中发现的一类天然化合物.
- 众所周知,卡斯塔诺普西斯属是各种植物化学物质的来源.
- 了解这些化合物的化学多样性和生物活性对于药物发现至关重要.
研究的目的:
- 从Castanopsis calathiformis中分离和表征新型的三烯酸.
- 评估分离化合物的α-葡萄糖酶抑制和抗增殖活性.
主要方法:
- 使用色谱技术分离化合物.
- 通过综合光谱分析 (NMR,MS) 阐明结构.
- 使用电子循环二元化 (ECD) 光谱和计算来确定绝对配置.
主要成果:
- 他们分离了9种三烯酸,包括6种新化合物.
- 化合物1-4,8和9表现出显著的α-葡萄糖酶抑制活性,表现优于阿卡尔.
- 化合物4对MCF-7细胞系表现出轻微的抗增殖活性.
结论:
- 卡斯塔诺普西斯 (Castanopsis calathiformis) 是结构多样化的三基酸的丰富来源.
- 隔离的化合物,特别是新型化合物,具有强大的α-葡萄糖酶抑制特性.
- 这些发现表明这些化合物的潜在治疗应用在与α-葡萄糖酶活性相关的条件的管理中.
相关概念视频
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
738
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
738
Dipeptidyl Peptidase 4 Inhibitors
845
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
845
Oral Hypoglycemic Agents: Biguanides and Glitazones
793
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
793


